Rhythm Pharmaceuticals, Inc. (RYTM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 60.11M | 57.25M | 51.3M | 48.5M | 32.7M | 41.83M | 33.25M | 29.08M | 25.97M | 24.23M | 22.5M | 19.22M |
| Revenue Growth % | 83.81% | 36.87% | 54.28% | 66.8% | 25.94% | 72.61% | 47.76% | 51.28% | 126.41% | 175.7% | 425.3% | 112.01% |
| Cost of Goods Sold | 7.16M | 4.8M | 5.5M | 5.54M | 3.65M | 3.79M | 3.83M | 2.95M | 2.81M | 3.23M | 2.41M | 2.24M |
| COGS % of Revenue | 11.91% | 8.39% | 10.72% | 11.43% | 11.15% | 9.05% | 11.51% | 10.13% | 10.81% | 13.34% | 10.72% | 11.63% |
| Gross Profit | 52.95M | 52.45M | 45.8M | 42.96M | 29.06M | 38.04M | 29.42M | 26.13M | 23.16M | 21M | 20.09M | 16.98M |
| Gross Margin % | 88.09% | 91.61% | 89.28% | 88.57% | 88.85% | 90.95% | 88.49% | 89.87% | 89.19% | 86.66% | 89.28% | 88.37% |
| Gross Profit Growth % | 82.25% | 37.87% | 55.66% | 64.4% | 25.46% | 81.15% | 46.44% | 53.85% | 130.49% | 170.56% | 430.55% | 95.5% |
| Operating Expenses | 105.32M | 99.51M | 98.45M | 88.25M | 76.06M | 79.3M | 73.31M | 66.61M | 163.05M | 62.27M | 64.05M | 63.59M |
| OpEx % of Revenue | 175.2% | 173.81% | 191.92% | 181.96% | 232.57% | 189.57% | 220.47% | 229.07% | 627.9% | 256.94% | 284.59% | 330.83% |
| Selling, General & Admin | 63.59M | 57.48M | 52.43M | 45.95M | 39.09M | 38.13M | 35.38M | 36.41M | 34.38M | 32.37M | 30.48M | 30.05M |
| SG&A % of Revenue | 105.79% | 100.4% | 102.2% | 94.73% | 119.52% | 91.15% | 106.39% | 125.23% | 132.41% | 133.59% | 135.42% | 156.32% |
| Research & Development | 41.73M | 42.03M | 46.03M | 42.31M | 36.97M | 41.17M | 37.93M | 30.02M | 128.47M | 29.89M | 33.57M | 33.54M |
| R&D % of Revenue | 69.41% | 73.42% | 89.72% | 87.23% | 113.05% | 98.42% | 114.07% | 103.23% | 494.76% | 123.35% | 149.17% | 174.51% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -52.36M | -47.06M | -52.65M | -45.3M | -47M | -41.26M | -43.88M | -40.48M | -139.89M | -41.27M | -43.95M | -46.6M |
| Operating Margin % | -87.11% | -82.2% | -102.64% | -93.39% | -143.73% | -98.63% | -131.98% | -139.2% | -538.71% | -170.28% | -195.31% | -242.46% |
| Operating Income Growth % | -11.4% | -14.08% | -19.98% | -11.9% | 66.4% | 0.02% | 0.15% | 13.14% | -166.29% | 1.99% | -11.93% | -3.34% |
| EBITDA | -52.36M | -46.79M | -52.35M | -44.92M | -46.62M | -40.87M | -43.5M | -40.09M | -139.48M | -40.85M | -43.51M | -46.16M |
| EBITDA Margin % | -87.11% | -81.73% | -102.05% | -92.61% | -142.55% | -97.71% | -130.82% | -137.86% | -537.15% | -168.56% | -193.35% | -240.16% |
| EBITDA Growth % | -12.31% | -14.48% | -20.34% | -12.05% | 66.58% | -0.06% | 0.03% | 13.16% | -167.85% | 1.95% | -12.07% | -3.37% |
| D&A (Non-Cash Add-back) | 0 | 272K | 304K | 379K | 383K | 383K | 385K | 390K | 405K | 417K | 442K | 442K |
| EBIT | 0 | -42.92M | -48.05M | -40.48M | -44.01M | -37.94M | -38.74M | -27.18M | -136.32M | -36.89M | -40.65M | -43.4M |
| Net Interest Income | 0 | -530K | -415K | -2.58M | -1.77M | -1.93M | -1.19M | -506K | -1.71M | -731K | 317K | -82K |
| Interest Income | 3.55M | 4.08M | 4.33M | 3.24M | 3.64M | 3.52M | 4.05M | 4.1M | 3.05M | 3.82M | 3.47M | 3.22M |
| Interest Expense | -4.58M | 4.62M | 4.74M | 5.82M | 5.41M | 5.45M | 5.24M | 4.6M | 4.75M | 4.55M | 3.15M | 3.3M |
| Other Income/Expense | -2.73M | -473K | -140K | -999K | -2.41M | -2.13M | -100K | 8.7M | -1.19M | -172K | 158K | -99K |
| Pretax Income | -55.09M | -47.54M | -52.79M | -46.3M | -49.42M | -43.38M | -43.98M | -31.78M | -141.07M | -41.44M | -43.8M | -46.7M |
| Pretax Margin % | -91.65% | -83.03% | -102.91% | -95.45% | -151.11% | -103.71% | -132.28% | -109.3% | -543.27% | -170.99% | -194.61% | -242.98% |
| Income Tax | 545K | -31K | 111K | 337K | 80K | -90K | -344K | 479K | 300K | 196K | 368K | 0 |
| Effective Tax Rate % | -0.99% | 0.07% | -0.21% | -0.73% | -0.16% | 0.21% | 0.78% | -1.51% | -0.21% | -0.47% | -0.84% | 0% |
| Net Income | -56.74M | -47.51M | -52.9M | -46.63M | -49.5M | -43.29M | -43.64M | -32.26M | -141.37M | -41.63M | -44.16M | -46.7M |
| Net Margin % | -94.4% | -82.97% | -103.13% | -96.14% | -151.35% | -103.5% | -131.25% | -110.95% | -544.43% | -171.8% | -196.25% | -242.98% |
| Net Income Growth % | -14.64% | -9.73% | -21.23% | -44.55% | 64.99% | -3.98% | 1.18% | 30.92% | -170.94% | 2.02% | -8.08% | -3.78% |
| Net Income (Continuing) | -56.74M | -47.51M | -52.9M | -46.63M | -49.5M | -43.29M | -43.64M | -32.26M | -141.37M | -41.63M | -44.16M | -46.7M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 | -2.35 | -0.70 | -0.76 | -0.82 |
| EPS Growth % | -2.47% | -1.39% | -15.49% | -41.51% | 65.53% | -2.86% | 6.58% | 35.37% | -158.24% | 6.67% | 8.43% | 7.87% |
| EPS (Basic) | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 | -2.35 | -0.70 | -0.76 | -0.82 |
| Diluted Shares Outstanding | 67.97M | 66.88M | 64.35M | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M |
| Basic Shares Outstanding | 67.97M | 66.88M | 64.35M | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |